Glooko, a leader in diabetes data management, has launched a new version of the Glooko Web Application (Population Tracker) that includes streamlined navigation and an assortment of diabetes analytics, charts and graphs.
The application will be available in the US and Canada. It includes support for IDC’s Ambulatory Glucose Profile (AGP), an important standard with clinicians. The application further includes the following new features:
• Insight into factors like exercise, carbs and medication influence glucose levels.
• Enhanced charts and graphs with new color coding to streamline data for easy interpretation.
• Enhanced insulin pump reports, bolus tracking features and
• Modified PDF wizard that provides easy report reviewing and sharing.
Glooko plans to begin the first phase for the European market launch later this year. The company attributes the launch of the new product to over a year of development and research in the diasend® and Glooko platforms to identify the most insightful analytics features for people with diabetes (PWDs) and clinicians. Glooko and diasend®, both diabetes data management companies merged in 2016.
“We are truly excited to supply PWDs and clinicians with the most comprehensive set of reports and analytics on diabetes data available today. We listened to our customers’ feedback and added new features that will allow users to further separate the data that really matters from background noise. Patients and clinicians can now efficiently gain actionable insights from their data better than ever before”, said Sam Wyndbrant, Director of Product Management at Glooko.